Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Soligenix, Inc. Common Stock (SNGX)

Pharmaceutical Preparations

https://www.soligenix.com

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

29 EMMONS DRIVE, SUITE B-10
PRINCETON, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/05/1994

Market Cap

8,642,564

Shares Outstanding

10,520,000

Weighted SO

10,524,437

Total Employees

N/A

Upcoming Earnings

08/19/2024

Similar Tickers

ZURA --.--%

APGN --.--%

PHIO --.--%

EFTR --.--%

IMMX --.--%

ADXN --.--%

ACGN --.--%

ERYP --.--%

ATXI --.--%

Beta

1.8720

Last Div

0.0000

Range

1.83-32.0

Chg

0.4499

Avg Vol

2627050

Mkt Cap

8642564

Exch

NASDAQ

Country

US

Phone

609 538 8200

DCF Diff

3.5311

DCF

0.3289

Div Yield

0.0000

P/S

17.4730

EV Multiple

-0.2639

P/FV

1.3771

Div Yield %

0.0000

P/E

-0.6775

PEG

-0.0081

Payout

0.0000

Current Ratio

1.5197

Quick Ratio

1.5197

Cash Ratio

1.4812

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1358.9553

CCC

-1358.9553

Gross Margin

0.0778

Op Margin

-16.4628

Pretax Margin

-15.4258

Net Margin

-14.2380

Eff Tax Rate

0.0916

ROA

-0.7139

ROE

-2.5663

ROCE

-2.3196

NI/EBT

0.9230

EBT/EBIT

0.9370

EBIT/Rev

-16.4628

Debt Ratio

0.2960

D/E

0.8428

LT Debt/Cap

0.0130

Total Debt/Cap

0.4573

Int Coverage

-137.9868

CF/Debt

-2.6626

Equity Multi

2.8472

Rec Turnover

0.0000

Pay Turnover

0.2686

Inv Turnover

0.0000

FA Turnover

2.7566

Asset Turnover

0.0501

OCF/Share

-6.1755

FCF/Share

-6.1755

Cash/Share

7.4763

OCF/Sales

-15.7187

FCF/OCF

1.0000

CF Coverage

-2.6626

ST Coverage

-2.7049

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.3771

P/B

1.3771

P/S

17.4730

P/E

-0.6775

P/FCF

-1.1116

P/OCF

-0.6137

P/CF

-0.6137

PEG

-0.0081

P/S

17.4730

EV Multiple

-0.2639

P/FV

1.3771

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation